| Product Information |
DR-XY43830_PI_01.pdf
|
| Registration Number |
DR-XY43830
|
| Generic Name |
Canagliflozin
|
| Brand Name |
Invokana
|
| Dosage Strength |
100 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Sodium-glucose co-transporter 2 (SGLT2) Inhibitor
|
| Packaging |
Alu/PVC blister pack x 10's
(Box of 3 blister packs x 10 tablets); Alu/PVC blister pack x 5's (Box of 1 blister pack x 5 tablets)
|
| Manufacturer |
Janssen Cilag S.P.A.
|
| Country of Origin |
Italy
|
| Trader |
|
| Importer |
Johnson & Johnson (Philippines), Inc.
|
| Distributor |
Johnson & Johnson (Philippines), Inc.
|
| Application Type |
Initial (from Monitored Release)
|
| Issuance Date |
16 June 2022
|
| Expiry Date |
23 October 2024
|